EVI-1 Gene expression among subjects with leukemia in Southern Nigeria; in vivo and in silico bioinformatics evaluation

Background: Hematological malignancies are a group of neoplastic conditions of lymphoid and hematopoietic tissues that culminate into leukemia, lymphoma, and myeloma. Gene expressions and biomarkers are often altered during hematological malignancies. Consequently, this study aims to determine EVI-1 (MECOM) gene expression in leukemias.